TLR7/9-activated IRF5 elevates IL-10 in systemic lupus erythematosus (SLE) models, contrasting with its pro-inflammatory role in TLR2/4-mediated pathways (80). This evidence concerns the gene TLR2 and systemic lupus erythematosus.